These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 17260221)
1. Women with hypogonadotropic hypogonadism: cycle characteristics and results of assisted reproductive techniques. Kumbak B; Kahraman S Acta Obstet Gynecol Scand; 2006; 85(12):1453-7. PubMed ID: 17260221 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization. Kumbak B; Kahraman S Acta Obstet Gynecol Scand; 2009; 88(5):563-8. PubMed ID: 19306135 [TBL] [Abstract][Full Text] [Related]
3. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization. Jiang S; Kuang Y Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429 [TBL] [Abstract][Full Text] [Related]
4. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol? Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177 [TBL] [Abstract][Full Text] [Related]
5. The reproductive outcome of women with hypogonadotropic hypogonadism undergoing in vitro fertilization. Yilmaz S; Ozgu-Erdinc AS; Yumusak O; Kahyaoglu S; Seckin B; Yilmaz N Syst Biol Reprod Med; 2015; 61(4):228-32. PubMed ID: 26042899 [TBL] [Abstract][Full Text] [Related]
6. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization]. Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490 [TBL] [Abstract][Full Text] [Related]
7. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989 [TBL] [Abstract][Full Text] [Related]
8. [Effect of pelvic inflammatory disease grades on in vitro fertilization-embryo transfer outcome]. Yang XE; Zhang SY Zhonghua Fu Chan Ke Za Zhi; 2007 Oct; 42(10):666-9. PubMed ID: 18241540 [TBL] [Abstract][Full Text] [Related]
9. Serum progesterone at human chorionic gonadotropin injection significantly correlate with female age. Doldi N; Persico P; De Santis L; Rabellotti E; Papaleo E; Ferrari A Minerva Ginecol; 2005 Aug; 57(4):477-82. PubMed ID: 16170294 [TBL] [Abstract][Full Text] [Related]
10. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes. Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961 [TBL] [Abstract][Full Text] [Related]
11. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Barad DH; Weghofer A; Gleicher N Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814 [TBL] [Abstract][Full Text] [Related]
12. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome. Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398 [TBL] [Abstract][Full Text] [Related]
13. [Gonadotrophin dose and ovarian response: relations to the clinical outcome of in vitro fertilization and embryo transfer]. Xiong XS; Chen SL; Sun L; Yin MN; Zhao EY; Song J Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):712-4. PubMed ID: 18504186 [TBL] [Abstract][Full Text] [Related]
14. [Serum estradiol the day of hCG administration as predictor factor of IVF-ET]. Kably Ambe A; Estévez González S; Carballo Mondragón E Ginecol Obstet Mex; 2008 Apr; 76(4):197-201. PubMed ID: 18798418 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-alpha (Gonal-F) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology. Moon SY; Choi YS; Ku SY; Kim SH; Choi YM; Kang IS; Kim CH J Obstet Gynaecol Res; 2007 Jun; 33(3):305-15. PubMed ID: 17578360 [TBL] [Abstract][Full Text] [Related]
16. Poor ovarian response in patients younger than 35 years: is it also a qualitative decline in ovarian function? Figueira Rde C; Braga DP; Nichi M; Madaschi C; Semião-Francisco L; Iaconelli A; Borges E Hum Fertil (Camb); 2009; 12(3):160-5. PubMed ID: 19544121 [TBL] [Abstract][Full Text] [Related]
17. The effect of withholding gonadotropin (a coasting period) on the outcome of in vitro fertilization cycles. Owj M; Tehrani Nejad ESh; Amirchaghmaghi E; Ezabadi Z; Baghestani AR Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):81-5. PubMed ID: 17229513 [TBL] [Abstract][Full Text] [Related]
18. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders. Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895 [TBL] [Abstract][Full Text] [Related]
19. The probability of successful IVF outcome after poor ovarian response. Saldeen P; Källen K; Sundström P Acta Obstet Gynecol Scand; 2007; 86(4):457-61. PubMed ID: 17486468 [TBL] [Abstract][Full Text] [Related]
20. Does gravidity influence the success of in vitro fertilization-embryo transfer cycles? Rabinson J; Bar-Hava I; Meltcer S; Zohav E; Anteby E; Orvieto R Gynecol Endocrinol; 2006 Apr; 22(4):175-8. PubMed ID: 16723302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]